Shilei Xu

1.2k total citations
34 papers, 620 citations indexed

About

Shilei Xu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shilei Xu has authored 34 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Shilei Xu's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (4 papers) and Plant Reproductive Biology (4 papers). Shilei Xu is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (4 papers) and Plant Reproductive Biology (4 papers). Shilei Xu collaborates with scholars based in China, Germany and United Kingdom. Shilei Xu's co-authors include Xiaohe Hu, Jun Yang, Da Luo, Yonghai Luo, Xianzhong Feng, Lin Weng, Guoguang Ying, Xin Li, Mike Ambrose and Shusei Sato and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and International Journal of Molecular Sciences.

In The Last Decade

Shilei Xu

34 papers receiving 614 citations

Peers

Shilei Xu

EEBS

ONCOL

Peter Peterson United States

Zenaida P. Lopez-Dee United States

Stefanie De Schepper Belgium

Claudia Sopalla Germany

J Dittmer United States

Jinling Cao China

Sang-Ho Jeong South Korea

Magdalena Olbryt Poland

Jong Ho Park South Korea

Yanfei Ma China

Peter Peterson United States

Shilei Xu

487 ×1.2

179 ×1.0

46 ×0.5

EEBS

115 ×1.2

ONCOL

59 ×0.8

Citations per year, relative to Shilei Xu Shilei Xu (= 1×) peers Peter Peterson

Countries citing papers authored by Shilei Xu

Since Specialization

Citations

This map shows the geographic impact of Shilei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilei Xu more than expected).

Fields of papers citing papers by Shilei Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilei Xu. The network helps show where Shilei Xu may publish in the future.

Co-authorship network of co-authors of Shilei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Shilei Xu. A scholar is included among the top collaborators of Shilei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilei Xu. Shilei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Yongzi, et al.. (2025). Characterization of novel sialylation-associated microRNA signature for prognostic assessment in breast cancer and its implications for the tumor microenvironment. The Journal of Steroid Biochemistry and Molecular Biology. 248. 106683–106683. 1 indexed citations

Chen, Baorong, Bangyu Wang, Xiaopeng Chen, et al.. (2023). Upregulation of NUAK2: A novel prognostic marker in breast cancer.. PubMed. 38(7). 811–822. 4 indexed citations

Huang, He, et al.. (2023). Single-cell transcriptomics reveals immune infiltrate in sepsis. Frontiers in Pharmacology. 14. 1133145–1133145. 13 indexed citations

Huang, He, et al.. (2022). Identification of a novel four-gene diagnostic signature for patients with sepsis by integrating weighted gene co-expression network analysis and support vector machine algorithm. Hereditas. 159(1). 14–14. 11 indexed citations

Zhang, Peng, Xiaojie Li, Ruomi Guo, et al.. (2021). Idiopathic acute superior mesenteric venous thrombosis after renal transplantation: A case report. World Journal of Clinical Cases. 9(32). 9896–9902. 1 indexed citations

Xu, Shilei, et al.. (2021). Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma. Translational Cancer Research. 10(6). 2859–2872. 12 indexed citations

Xu, Shilei, et al.. (2021). The clinical value of serum hepatic parenchyma cell volume-normalized hepatitis B surface antigen levels in hepatitis B e antigen -positive and -negative chronic hepatitis B patients. Annals of Translational Medicine. 9(18). 1431–1431. 1 indexed citations

Dolff, Sebastian, Shilei Xu, Ming Sun, et al.. (2021). Characterization of follicular T helper cells and donor-specific T helper cells in renal transplant patients with de novo donor-specific HLA-antibodies. Clinical Immunology. 226. 108698–108698. 4 indexed citations

Zheng, Yongfa, Chengliang Zhu, Yu Si, et al.. (2019). Hepatitis B virus X protein–induced SH2 domain–containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5–transketolase interaction. Journal of Biological Chemistry. 294(13). 4815–4827. 21 indexed citations

10.

Hu, Hua, Jie Chen, Lujun Zhao, et al.. (2019). Fluzoparib increases radiation sensitivity of non-small cell lung cancer (NSCLC) cells without BRCA1/2 mutation, a novel PARP1 inhibitor undergoing clinical trials. Journal of Cancer Research and Clinical Oncology. 146(3). 721–737. 22 indexed citations

11.

Sun, Ming, Shilei Xu, Sebastian Dolff, et al.. (2019). Expression pattern of co-inhibitory molecules on CMV-specific T-cells in lung transplant patients. Clinical Immunology. 208. 108258–108258. 1 indexed citations

12.

Lindemann, Monika, Johannes Korth, Ming Sun, et al.. (2018). The Cytomegalovirus-Specific IL-21 ELISpot Correlates with Allograft Function of Kidney Transplant Recipients. International Journal of Molecular Sciences. 19(12). 3945–3945. 11 indexed citations

13.

Wang, Qingliang, Xiaojie Li, Zhicheng Yao, et al.. (2017). Sorafenib-induced acute-on-chronic liver failure in a patient with hepatocellular carcinoma after transarterial chemoembolization and radiofrequency ablation: A case report. Molecular and Clinical Oncology. 7(4). 693–695. 3 indexed citations

14.

Wang, Qian, Yiman Tang, Yue Xu, et al.. (2017). The X-linked deubiquitinase USP9X is an integral component of centrosome. Journal of Biological Chemistry. 292(31). 12874–12884. 27 indexed citations

15.

Xu, Zhiyong, Kai Cheng, Xin Li, et al.. (2016). Transcriptional and Post-transcriptional Modulation of SQU and KEW Activities in the Control of Dorsal–Ventral Asymmetric Flower Development in Lotus japonicus. Molecular Plant. 9(5). 722–736. 7 indexed citations

16.

Liu, Jianrong, Shilei Xu, Yuling An, et al.. (2015). Effect of early enteral nutrition on recovery of patients with severe hepatitis after liver transplantation. 4(5). 306–310. 1 indexed citations

17.

Liu, Bo, Zhicheng Yao, Kunpeng Hu, et al.. (2015). ShRNA-mediated silencing of the Ndc80 gene suppress cell proliferation and affected hepatitis B virus-related hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. 40(3). 297–303. 14 indexed citations

18.

Xu, Shilei, Yonghai Luo, Zhigang Cai, et al.. (2012). Functional Diversity of CYCLOIDEA‐like TCP Genes in the Control of Zygomorphic Flower Development in Lotus japonicus. Journal of Integrative Plant Biology. 55(3). 221–231. 24 indexed citations

19.

Weng, Lin, Zhaoxia Tian, Xianzhong Feng, et al.. (2011). Petal Development in Lotus japonicus. Journal of Integrative Plant Biology. 53(10). 770–782. 22 indexed citations

20.

Wang, Zheng, Yonghai Luo, Xin Li, et al.. (2008). Genetic control of floral zygomorphy in pea ( Pisum sativum L.). Proceedings of the National Academy of Sciences. 105(30). 10414–10419. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact